• Guideline Summary
  • NGC:009132
  • 2002 Mar (revised 2012 May)

Gastroesophageal reflux disease (GERD).

  • Guideline Summary
  • NGC:010502
  • 2014 Jun

Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for ivacaftor therapy in the context of CFTR genotype.

  • Guideline Summary
  • NGC:010331
  • 2014 Feb

Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for IFNL3 (IL28B) genotype and PEG interferon-α–based regimens.

  • Guideline Summary
  • NGC:010591
  • 2014 Aug

Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for rasburicase therapy in the context of G6PD deficiency genotype.

  • Guideline Summary
  • NGC:009051
  • 2012 Feb

Guideline for the management of bleeding on Dabigatran (Pradaxa).

  • Guideline Summary
  • NGC:010769
  • 2015 Jul

Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for CYP3A5 genotype and tacrolimus dosing.

  • Guideline Summary
  • NGC:011000
  • 2016 Apr

Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for UGT1A1 and atazanavir prescribing.

  • Guideline Summary
  • NGC:009375
  • 2012 Oct

Psoriasis: the assessment and management of psoriasis.

  • Guideline Summary
  • NGC:010345
  • 2014 Mar

A.S.P.E.N. clinical guidelines: parenteral nutrition ordering, order review, compounding, labeling, and dispensing.

  • Guideline Summary
  • NGC:009523
  • 2012 Oct

Guiding principles for the care of older adults with multimorbidity: an approach for clinicians.

  • Guideline Summary
  • NGC:009196
  • 2012 Jun

Sickle cell acute painful episode: management of an acute painful sickle cell episode in hospital.

  • Guideline Summary
  • NGC:009478
  • 2013 Jan

Guideline on the management of bleeding in patients on antithrombotic agents.

  • Guideline Summary
  • NGC:009997
  • 2010 Aug (revised 2013 Jul)

Optimal use recommendations for second- and third-line therapy for patients with type 2 diabetes.

  • Guideline Summary
  • NGC:010224
  • 2007 Apr 13 (revised 2013 Dec 16)

Safe handling of cytotoxics.

  • Guideline Summary
  • NGC:010944
  • 2015 Sep 18

Therapeutic drug monitoring of vancomycin: a guideline of the Division of Therapeutic Drug Monitoring, Chinese Pharmacological Society.